Complexa, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Pittsburgh PA United States (2008)

Organization Overview

First Clinical Trial
2014
NCT02127190
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Complexa, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Kidney Injury (Phase 1)

Familial Primary Pulmonary Hypertension (Phase 2)

Glomerulosclerosis, Focal Segmental (Phase 2)

Hypertension (Phase 2)

Wounds and Injuries (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 9
  • # of Trial APIs: 9